Millennium Management’s Intersect ENT, Inc XENT Stock Holding History

Millennium Management’s Portfolio XENT Stock Details XENT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-10,000	Closed	-$229K	–	6714
2020 Q4	$229K	Buy	+10,000	New	+$190K	﹤0.01%	4732
2020 Q1	–	Sell	-40,000	Closed	-$996K	–	4748
2019 Q4	$996K	Hold	40,000	–	–	﹤0.01%	3005
2019 Q3	$680K	Sell	40,000 -230,800	-85%	-$4.2M	﹤0.01%	3073
2019 Q2	$6.16M	Buy	270,800 +70,800	+35%	+$1.91M	0.01%	1615
2019 Q1	$6.43M	Buy	200,000 +115,000	+135%	+$3.56M	0.01%	1582
2018 Q4	$2.4M	Sell	85,000 -45,000	-35%	-$1.32M	﹤0.01%	2090
2018 Q3	$3.74M	Buy	130,000 +110,000	+550%	+$3.3M	﹤0.01%	2013
2018 Q2	$749K	Buy	+20,000	New	+$785K	﹤0.01%	2983
2018 Q1	–	Sell	-100,000	Closed	-$3.24M	–	4223
2017 Q4	$3.24M	Hold	100,000	–	–	﹤0.01%	1980
2017 Q3	$3.12M	Buy	100,000 +50,000	+100%	+$1.48M	﹤0.01%	1935
2017 Q2	$1.4M	Sell	50,000 -50,000	-50%	-$1.13M	﹤0.01%	2279
2017 Q1	$1.72M	Buy	+100,000	New	+$1.4M	﹤0.01%	2087

Millennium Management's XENT Position: Q2 2022 in Review

Millennium Management sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 510,536 shares — an estimated $14.3M sold.

Millennium Management first reported a position in XENT in Q3 2014 and held it in 25 quarters. The position peaked at $43.1M in Q1 2019. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.

Millennium Management reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
Millennium Management sold 510,536 Intersect ENT, Inc shares in Q2 2022, an estimated $14.3M.
Millennium Management first reported a position in Intersect ENT, Inc in Q3 2014 and held it in 25 quarters.
Millennium Management's Intersect ENT, Inc position peaked at $43.1M in Q1 2019.
0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.

Based on Millennium Management's 13F filing for Q2 2022, filed 15 Aug 2022.